Augmedix

Augmedix

Converts clinician conversations into structured notes

Overview

Augmedix uses ambient AI to reduce clinicians' administrative work by turning natural conversations into structured medical notes and actionable data. Conversations are captured at the point of care and processed by AI to generate notes, trigger real-time alerts, and feed decision-support, with data integrated across care settings. It emphasizes real-time ambient transcription and structured interoperable data across care environments, delivered as a subscription SaaS that adds clinical decision support. Its goal is to lessen administrative burden on clinicians while improving patient care, operational efficiency, and financial outcomes for healthcare providers.

Significant Headcount Growth

About Augmedix

Simplify's Rating
Why Augmedix is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

201-500

Company Stage

IPO

Headquarters

San Francisco, California

Founded

2012

Your Connections

People at Augmedix who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquired by Commure for $139M in late 2024, enabling scaled AI innovation.
  • Partners with Emergency Services Inc. across seven Ohio facilities, saving one hour daily.
  • Featured in Epic Showroom, supporting 50+ specialties and 30+ languages.

What critics are saying

  • Nabla Copilot offers free scribing, eroding Augmedix subscriptions in 6-12 months.
  • Microsoft Dragon Copilot blocks Epic integrations, diverting 40% hospital contracts.
  • Google MedLM deploys directly via HCA, bypassing Augmedix in 12-24 months.

What makes Augmedix unique

  • Augmedix Go ED automates ED notes using Google Cloud’s MedLM and fine-tuned LLMs.
  • Integrates with over 50 EHRs including Epic, Oracle Health, and MEDITECH.
  • Secured Vizient contract on January 13, 2025, for nationwide provider access.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$283M

Above

Industry Average

Funded Over

9 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison
Coming Soon

Stock Price

Growth & Insights and Company News

Headcount

6 month growth

6%

1 year growth

6%

2 year growth

21%
HIT Consultant
Jan 13th, 2025
Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions

Augmedix Go seamlessly integrates with over 50 EHR systems, including Epic, Oracle Health, and MEDITECH, making it a versatile solution for various healthcare settings.

HIT Consultant
Jan 13th, 2025
Augmedix Awarded Vizient Contract For Ambient Ai Documentation Solutions

Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions. by Fred Pennic 01/13/2025 Leave a Comment. What You Should Know: – Augmedix, a leader in ambient AI medical documentation and a wholly-owned subsidiary of Commure has secured a contract with Vizient, the nation’s largest provider-driven healthcare performance improvement company. – The agreement grants Vizient’s extensive network of healthcare providers access to Augmedix’s comprehensive suite of AI-powered documentation solutions.Streamlining Documentation with AIVizient serves a vast majority of acute care providers, academic medical centers, and non-acute care facilities across the United States. Its diverse customer base, representing over $140 billion in annual purchasing volume, includes pediatric facilities, community hospitals, and integrated health delivery networks.Through this contract, Vizient members can now leverage Augmedix Go, a cost-effective and scalable AI documentation solution that automatically generates medical notes from natural clinician-patient conversations. This technology empowers providers to:Reduce administrative burden: Freeing up clinicians from time-consuming documentation tasks.Improve operational efficiency: Streamlining workflows and optimizing clinical documentation processes.Enhance clinician and patient experiences: Allowing clinicians to focus more on patient interaction and care delivery.Broad Compatibility and IntegrationAugmedix Go seamlessly integrates with over 50 EHR systems, including Epic, Oracle Health, and MEDITECH, making it a versatile solution for various healthcare settings. This compatibility ensures that providers can easily incorporate Augmedix’s technology into their existing workflows.“We are excited to introduce Vizient’s provider clients to the transformative potential of Ambient Clinical Documentation,” said Ian Shakil, founder of Augmedix and Chief Strategy Officer of Commure

Healthcare IT Today
Aug 9th, 2024
Augmedix Acquired by Commure for $139M

Augmedix, Inc. will be acquired by Commure, Inc. in an all-cash transaction valued at approximately $139 million. Augmedix stockholders will receive $2.35 per share, a 169% premium over the 30-day VWAP ending July 18, 2024. Augmedix will become a wholly-owned subsidiary of Commure. CEO Manny Krakaris stated that the acquisition will enhance Augmedix's ability to scale and innovate its ambient AI medical documentation solutions.

HIT Consultant
Jul 19th, 2024
Commure To Acquire Augmedix In $139M All-Cash Deal

Commure to Acquire Augmedix in $139M All-Cash Deal by Fred Pennic 07/19/2024 Leave a Comment What You Should Know:  – Augmedix (AUGX), a leader in AI-powered medical documentation and data solutions, is being acquired by healthcare technology provider Commure in an all-cash deal valued at approximately $139M. News of the acquisition brought Augmedix up by 150% at $2.27 at 10 am ET after closing at $0.92 on Thursday.  – Augmedix leverages AI technology to streamline medical documentation and data management for healthcare providers. Their platform uses ambient AI to convert natural conversations into organized medical notes, improving efficiency and clinical decision-making. – The combined company aims to leverage AI and automation to reduce administrative tasks for healthcare professionals, allowing them to spend more time with patients. This could lead to improved patient outcomes, increased provider satisfaction, and a more efficient healthcare system overall. Terms of the Agreement: Augmedix shareholders will receive $2.35 per share.This represents a premium of 169% over Augmedix’s 30-day stock price average.Commure will acquire all outstanding Augmedix shares.The transaction is expected to close in late Q3 or early Q4 of 2024, subject to shareholder approval and customary closing conditions.Upon closing, Augmedix will become a private subsidiary of Commure and its stock will be delisted

Fierce Healthcare
Jul 19th, 2024
Health tech company Commure to acquire Augmedix in $139M deal as AI scribe competition heats up

Health tech company Commure to acquire Augmedix in $139M deal as AI scribe competition heats up.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Augmedix right now.

Find jobs on Simplify and start your career today

We update Augmedix's jobs every few hours, so check again soon! Browse all jobs →